Synthetic inhibition of the SUMO pathway by targeting the SAE1 component via TAK-981 compound impairs growth and chemosensitizes embryonal and alveolar rhabdomyosarcoma cell lines
Silvia Codenotti(University of Brescia), Stefano Gastaldello(Karolinska Institutet)
Cited by 0